SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
06-May-22 6:00 AM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 02-May-22 | Purchase | 1,151,520 | $1.65 | $1,900,000.00 | 32% 3.55M to 4.7M | |
27-Apr-21 11:09 AM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 22-Apr-21 | Market Purchase | 27,000 | $2.08 | $56,215.30 | < 1% 3.52M to 3.55M | 1% |
27-Apr-21 11:09 AM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 21-Apr-21 | Market Purchase | 13,000 | $2.08 | $27,057.80 | < 1% 3.51M to 3.52M | 1% |
12-Jul-19 2:07 PM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 10-Jul-19 | Market Purchase | 7,000 | $1.73 | $12,103.60 | < 1% 3.5M to 3.51M | 44% |
10-Jul-19 10:59 AM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 09-Jul-19 | Market Purchase | 7,000 | $1.63 | $11,400.20 | < 1% 3.5M to 3.5M | 53% |
09-Jul-19 1:59 PM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 05-Jul-19 | Market Purchase | 9,000 | $1.45 | $13,049.10 | < 1% 3.49M to 3.5M | 72% |
03-Jul-19 4:18 PM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 03-Jul-19 | Market Purchase | 8,000 | $1.54 | $12,353.60 | < 1% 3.48M to 3.49M | 61% |
02-Jul-19 11:33 AM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 01-Jul-19 | Market Purchase | 9,000 | $1.37 | $12,305.20 | < 1% 3.47M to 3.48M | 82% |
01-Jul-19 3:13 PM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 29-Jun-19 | Purchase | 8,890 | $16.87 | $149,931.00 | < 1% 3.46M to 3.47M | |
01-Jul-19 3:13 PM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 28-Jun-19 | Market Purchase | 1,110 | $1.48 | $1,637.25 | < 1% 3.46M to 3.46M | 69% |
28-Jun-19 3:53 PM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 27-Jun-19 | Market Purchase | 9,000 | $1.56 | $14,023.20 | < 1% 3.45M to 3.46M | 61% |
27-Jun-19 11:14 AM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 26-Jun-19 | Market Purchase | 8,000 | $1.71 | $13,680.00 | < 1% 3.44M to 3.45M | 46% |
26-Jun-19 11:41 AM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 25-Jun-19 | Market Purchase | 9,000 | $1.73 | $15,532.70 | < 1% 3.43M to 3.44M | 45% |
21-Jun-19 11:55 AM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 20-Jun-19 | Market Purchase | 9,000 | $1.77 | $15,918.30 | < 1% 3.43M to 3.43M | 41% |
20-Jun-19 12:57 PM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 19-Jun-19 | Market Purchase | 8,000 | $1.69 | $13,528.80 | < 1% 3.42M to 3.43M | 48% |
19-Jun-19 2:27 PM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 18-Jun-19 | Market Purchase | 9,000 | $1.67 | $15,046.00 | < 1% 3.41M to 3.42M | 48% |
18-Jun-19 12:19 PM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 13-Jun-19 | Market Purchase | 8,000 | $1.42 | $11,344.00 | < 1% 3.4M to 3.41M | 75% |
12-Jun-19 10:53 AM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 11-Jun-19 | Market Purchase | 9,000 | $1.46 | $13,148.60 | < 1% 3.39M to 3.4M | 70% |
12-Jun-19 10:27 AM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 10-Jun-19 | Market Purchase | 8,000 | $1.54 | $12,288.00 | < 1% 3.38M to 3.39M | 62% |
07-Jun-19 11:42 AM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 06-Jun-19 | Market Purchase | 10,000 | $1.56 | $15,648.30 | < 1% 3.37M to 3.38M | 59% |
06-Jun-19 11:15 AM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 05-Jun-19 | Market Purchase | 11,000 | $1.55 | $17,092.70 | < 1% 3.36M to 3.37M | 60% |
04-Jun-19 4:33 PM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 03-Jun-19 | Market Purchase | 9,000 | $1.62 | $14,598.00 | < 1% 3.35M to 3.36M | 53% |
04-Jun-19 4:28 PM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 31-May-19 | Market Purchase | 10,000 | $1.59 | $15,924.80 | < 1% 3.34M to 3.35M | 56% |
31-May-19 12:11 PM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 30-May-19 | Market Purchase | 8,500 | $1.76 | $14,967.30 | < 1% 3.34M to 3.34M | 41% |
30-May-19 10:51 AM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 28-May-19 | Market Purchase | 9,000 | $1.68 | $15,097.50 | < 1% 3.33M to 3.34M | 48% |
28-May-19 12:19 PM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 24-May-19 | Market Purchase | 8,000 | $1.59 | $12,749.60 | < 1% 3.32M to 3.33M | 56% |
28-May-19 12:14 PM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 23-May-19 | Market Purchase | 7,500 | $1.55 | $11,656.50 | < 1% 3.31M to 3.32M | 60% |
03-Jan-19 1:09 PM View: | Danielsen Erik CFO | Nymox Pharmaceutical Corpor... (NYMX) | 21-Dec-18 | Market Purchase | 6,000 | $1.35 | $8,085.00 | 40% 14.9K to 20.9K | 84% |
03-Jan-19 1:05 PM View: | Danielsen Erik CFO | Nymox Pharmaceutical Corpor... (NYMX) | 19-Dec-18 | Market Purchase | 5,000 | $1.54 | $7,711.00 | 51% 9.9K to 14.9K | 61% |
14-Dec-18 3:58 PM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 13-Dec-18 | Market Purchase | 5,237 | $1.72 | $9,007.12 | < 1% 3.31M to 3.31M | 44% |
13-Dec-18 10:43 AM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 12-Dec-18 | Market Purchase | 6,000 | $1.71 | $10,285.20 | < 1% 3.3M to 3.31M | 44% |
12-Dec-18 10:16 AM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 11-Dec-18 | Market Purchase | 5,000 | $1.67 | $8,359.00 | < 1% 3.29M to 3.3M | 48% |
11-Dec-18 10:28 AM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 10-Dec-18 | Market Purchase | 7,500 | $1.62 | $12,132.00 | < 1% 3.29M to 3.29M | 53% |
10-Dec-18 11:41 AM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 07-Dec-18 | Market Purchase | 7,000 | $1.69 | $11,820.90 | < 1% 3.28M to 3.29M | 47% |
07-Dec-18 2:09 PM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 06-Dec-18 | Market Purchase | 1,400 | $1.74 | $2,436.00 | < 1% 3.28M to 3.28M | 42% |
06-Dec-18 2:34 PM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 04-Dec-18 | Market Purchase | 7,500 | $1.72 | $12,899.20 | < 1% 3.27M to 3.28M | 44% |
03-Dec-18 3:43 PM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 30-Nov-18 | Market Purchase | 5,000 | $1.84 | $9,200.00 | < 1% 3.27M to 3.27M | 35% |
30-Nov-18 2:29 PM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 29-Nov-18 | Market Purchase | 7,000 | $1.81 | $12,660.20 | < 1% 3.26M to 3.27M | 37% |
28-Nov-18 3:13 PM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 27-Nov-18 | Market Purchase | 8,000 | $1.71 | $13,679.20 | < 1% 3.25M to 3.26M | 45% |
21-Nov-18 10:56 AM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 20-Nov-18 | Market Purchase | 6,000 | $1.78 | $10,705.80 | < 1% 3.24M to 3.25M | 39% |
21-Nov-18 10:51 AM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 19-Nov-18 | Market Purchase | 9,000 | $1.74 | $15,675.30 | < 1% 3.24M to 3.24M | 42% |
21-Nov-18 10:43 AM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 16-Nov-18 | Market Purchase | 6,000 | $1.93 | $11,580.00 | < 1% 3.23M to 3.24M | 28% |
15-Nov-18 2:50 PM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 13-Nov-18 | Market Purchase | 7,000 | $2.00 | $13,993.70 | < 1% 3.22M to 3.23M | 24% |
13-Nov-18 9:39 AM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 09-Nov-18 | Market Purchase | 13,000 | $2.09 | $27,224.60 | < 1% 3.21M to 3.22M | 18% |
09-Nov-18 9:47 AM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 07-Nov-18 | Market Purchase | 363 | $2.04 | $740.48 | < 1% 3.21M to 3.21M | 21% |
06-Nov-18 11:36 AM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 02-Nov-18 | Market Purchase | 7,000 | $1.98 | $13,841.60 | < 1% 3.2M to 3.21M | 25% |
02-Nov-18 3:46 PM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 01-Nov-18 | Market Purchase | 6,000 | $1.90 | $11,400.00 | < 1% 3.2M to 3.2M | 30% |
01-Nov-18 3:17 PM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 31-Oct-18 | Market Purchase | 12,000 | $1.79 | $21,499.20 | < 1% 3.18M to 3.2M | 38% |
01-Nov-18 3:11 PM View: | Robinson James George Director | Nymox Pharmaceutical Corpor... (NYMX) | 30-Oct-18 | Market Purchase | 6,000 | $1.78 | $10,665.00 | < 1% 3.18M to 3.18M | 39% |
06-Nov-18 5:26 PM View: | Averback Paul CEO Director 10% Owner | Nymox Pharmaceutical Corpor... (NYMX) | 29-Oct-18 | Private Sale | 1,687,600 | $2.50 | $4,219,000.00 | (7%) 23.33M to 21.64M |